Challenges and opportunities for checkpoint blockade in T-cell lymphoproliferative disorders

The T-cell lymphoproliferative disorders are a heterogeneous group of non-Hodgkin’s lymphomas (NHL) for which current therapeutic strategies are inadequate, as most patients afflicted with these NHL will succumb to disease progression within 2 years of diagnosis. Appreciation of the genetic and immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Phillips, Tycel, Devata, Sumana, Wilcox, Ryan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5170899/
https://www.ncbi.nlm.nih.gov/pubmed/28031823
http://dx.doi.org/10.1186/s40425-016-0201-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5170899/
https://www.ncbi.nlm.nih.gov/pubmed/28031823
http://dx.doi.org/10.1186/s40425-016-0201-6

Ejemplares similares